Your body is adjusting to a new dual receptor agonist
One of the most common culprits is reduced-calorie intake
Studies show that 5-amino-1-methylquinolinium injection inhibits NNMT, normalizes nicotinamide metabolism, elevates NAD+, reduces oxidative stress in cells, suppresses apoptosis, preserves cell function, and promotes insulin secretion, supporting longterm glycemic control
Searches like long term results semaglutide vs surgery show that consistency is the key factor
Patients who remain on semaglutide or tirzepatide for years tend to maintain their weight loss, with some continuing to lose additional weight even after the first year
Some programs also feature support groups where patients can share experiences and tips